1/28/2025 | BKHYIG | S&P stabilizes Charles River outlook
|
6/26/2024 | BKHYIG | S&P goes positive on Charles River
|
3/16/2023 | BKBWHYIGLM | Charles River Labs continues lowering leverage through debt repayment
|
6/21/2022 | BKHYIG | Fitch gives Charles River loan BBB, notes BBB-
|
1/11/2022 | BWHYLM | Charles River Labs lifts leverage target after M&As to 3.5x from 3x
|
3/9/2021 | HY | Market Commentary: Primary reasonably busy; secondary firms; Charles River gains; Alcoa in focus
|
3/8/2021 | HY | Market Commentary: Charles River, Alcoa price; forward calendar grows; Playtika holds; Twilio active
|
3/8/2021 | HY | New Issue: Charles River prices $1 billion unsecured notes two tranches
|
3/8/2021 | BKHY | Moody's assigns Charles River notes Ba2
|
3/8/2021 | HY | Charles River driving by with $1 billion notes in eight-year and 10-year tranches
|
3/8/2021 | BKHY | S&P assigns Charles River notes BB
|
3/8/2021 | HYLM | Charles River Laboratories to redeem 5½% notes due 2026
|
2/17/2021 | BKBWHY | Charles River leverage to rise from purchase; debt markets considered
|
11/20/2020 | BKHY | Moody's upgrades Charles River
|
2/11/2020 | BKBWHY | Charles River Labs aims for 3x leverage; debt reduction is a priority
|
10/22/2019 | HY | New Issue: Charles River Laboratories prices $500 million 8.5-year notes at par to yield 4¼%
|
10/21/2019 | BKHY | Moody’s ups Charles River notes, rates new notes Ba3
|
10/21/2019 | BKHY | S&P assigns BB to Charles River bonds
|
10/21/2019 | HY | Charles River guiding $500 million notes due 2028 at 4½%-4¾% area
|
6/5/2019 | BKBWHYIG | Charles River Labs aims to keep leverage below 3x, but may go higher
|
5/1/2019 | BKCVHYIG | S&P lowers Charles River to junk
|
2/14/2019 | BKCVHYIG | S&P puts Charles River on watch
|
4/10/2018 | HY | Market Commentary: Hilton, Silversea upsize; junk market strong; Sprint up on merger news; Tenneco down
|
3/29/2018 | HY | Market Commentary: Ply Gem, Wyndham, W/S price; McDermott delayed; recent deals mixed; funds off $0.62 billion
|
3/28/2018 | HY | Market Commentary: Coty, Charles River price; McDermott widens talk; Tronox trades down; Tesla dominates
|
3/28/2018 | HY | New Issue: Charles River Laboratories prices $500 million eight-year notes at par to yield 5½%
|
3/28/2018 | HY | Market Commentary: Morning Commentary: McDermott downsized, heard to be widening; Boyne bonds soar
|
3/26/2018 | BKHYIG | Moody’s ups Charles River loans, rates notes B1
|
3/26/2018 | BKHYIG | S&P rates Charles River notes BB+
|
3/26/2018 | HY | Market Commentary: Morning Commentary: Busy pre-Easter calendar continues to build; new Cequel 7½% notes trading well
|
3/26/2018 | HY | Charles River Laboratories to sell $500 million eight-year notes during March 26 week
|
9/29/2006 | BKHY | Moody's introduces new ratings
|
8/9/2006 | BTCVHY | Charles River Labs files automatic shelf registration
|
2/26/2003 | HY | Moody's upgrades Chesapeake, rates notes Ba3, converts B3
|
2/13/2002 | HY | Tenders
|
1/30/2002 | HY | Tenders
|
1/17/2002 | HY | Tenders
|
1/16/2002 | HY | Moody's downgrades Kmart two notches, still on review
|
12/11/2001 | HY | S&P cuts Dana to junk
|